EndoChoice IPO update: Common stock price set at $15 per share

EndoChoice has announced the pricing for its initial public offering of 6.35 million shares of common stock.

The common stock will be sold at $15 per share. EndoChoice stock is expected to begin trading on the New York Stock Exchange under the symbol "GI" today.

J.P. Morgan and BofA Merrill Lynch are acting as joint booking-running managers of the offering. William Blair and Stifel are co-managers of the offering.

The underwriters of the offering have a 30-day option to purchase up to an additional 952,000 shares.

More articles on gastroenterology:
Gastro Health launches online support community for GI patients: 4 key notes
Boston Scientific co-founder John Abele receives lifetime achievement award
FDA clears 2 GI/endoscopy devices in May

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months